PDF Número - Nefrología

originales
Rafael Sánchez-Villanueva et al. Índice HOMAIR en pacientes no diabéticos en DP
27. Furuya R, Odamaki M, Kumagai H, Hishida A. Beneficial effects of
icodextrin on plasma level of adipocytokines in peritoneal dialysis
patients. Nephrol Dial Transplant 2006;21(2):494-8.
28. Cho KH, Do JY, Park JW, Yoon KW. Effect of icodextrin dialysis
solution on body weight and fat accumulation over time in CAPD
patients. Nephrol Dial Transplant 2010;25(2):593-9.
29. Bonora E, Targher G, Alberiche M, Bonadonna RC, Saggiani F,
Zenere MB, et al. Homeostasis model assessment closely mirrors
the glucose clamp technique in the assessment of insulin sensitivity:
studies in subjects with various degrees of glucose tolerance and
insulin sensitivity. Diabetes Care 2000;23(1):57-63.
30. Després JP, Lamarche B, Mauriège P, Cantin B, Dagenais GR,
Moorjani S, et al. Hyperinsulinemia as an independent risk factor
for ischemic heart disease. N Engl J Med 1996;334(15):952-7.
31. Hargreaves AD, Logan RL, Elton RA, Buchanan KD, Oliver MF,
Riemersma RA. Glucose tolerance, plasma insulin, HDL cholesterol
and obesity: 12-year follow-up and development of coronary heart
disease in Edinburgh men. Atherosclerosis 1992;94(1):61-9.
32. Ginsberg HN. Insulin resistance and cardiovascular disease. J Clin
Invest 2000;106(4):453-8.
33. McFarlane SI, Banerji M, Sowers JR. Insulin resistance and
cardiovascular disease. J Clin Endocrinol Metab 2001;86(2):713-8.
34. Shinohara K, Shoji T, Emoto M, Tahara H, Koyama H, Ishimura E,
et al. Insulin resistance as an independent predictor of
cardiovascular mortality in patients with end-stage renal disease. J
Am Soc Nephrol 2002;13(7):1894-900.
35. Becker B, Kronenberg F, Kielstein JT, Haller H, Morath C, Ritz E,
et al. Renal insulin resistance syndrome, adiponectin and
cardiovascular events in patients with kidney disease: the mild and
moderate kidney disease study. J Am Soc Nephrol
2005;16(4):1091-8.
36. Bonora E, Targher G, Alberiche M, Bonadonna RC, Saggiani F,
Zenere MB, et al. Homeostasis model assessment closely mirrors
the glucose clamp technique in the assessment of insulin sensitivity:
studies in subjects with various degrees of glucose tolerance and
insulin sensitivity. Diabetes Care 2000;23(1):57-63.
37. Yeni-Komshian H, Carantoni M, Abbasi F, Reaven GM. Relationship
between several surrogate estimates of insulin resistance and
quantification of insulin-mediated glucose disposal in 490 healthy
nondiabetic volunteers. Diabetes Care 2000;23(2):171-5.
38. Díez JJ, Grande C, Méndez J, González-Gancedo P, Iglesias P.
Growth hormone and insulin-like growth factor binding protein-1
responses to oral glucose in patients with primary
hyperparathyroidism. Clin Endocrinol (Oxf) 2006;65(1):27-34.
39. Gayoso-Diz P, Otero-Gonzalez A, Rodriguez-Alvarez MX, Gude F,
Cadarso-Suarez C, García F, et al. Insulin resistance index (HOMA-IR)
levels in a general adult population: curves percentile by gender and
age. The EPIRCE study. Diabetes Res Clin Pract 2011;94(1):146-55.
40. Caravaca F, Cerezo I, Macías R, García de Vinuesa E, Martínez del
Viejo C, Villa J, et al. [Insulin resistance in chronic kidney disease:
its clinical characteristics and prognosis significance]. Nefrologia
2010;30(6):661-8.
Enviado a Revisar: 9 Mar. 2012 | Aceptado el: 2 Nov. 2012
92
Nefrologia 2013;33(1):85-92